Helsinn Therapeutics (U.S.), Inc clinical trials
Acquired by Helsinn Healthcare SA
The registry lists 10 studies whose lead sponsor is Helsinn Therapeutics (U.S.), Inc. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 4, 2020.
Status
- Completed
- 10
Registry sponsor names on this page
- Helsinn Therapeutics (U.S.), Inc10 studies
Something wrong with this grouping? Tell us on the Helsinn Healthcare SA page.
Studies
Recruiting first, then most recently updated. Showing 10 of 10. All Helsinn Healthcare SA studies →
- Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell LymphomaCompletedNCT02296164
Sponsor listed in the registry: Helsinn Therapeutics (U.S.), Inc · Helsinn Therapeutics (U.S.), Inc — acquired company within the Helsinn Healthcare SA group
- Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 2)CompletedNCT01387282Phase 3
Sponsor listed in the registry: Helsinn Therapeutics (U.S.), Inc · Helsinn Therapeutics (U.S.), Inc — acquired company within the Helsinn Healthcare SA group
- Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 1)CompletedNCT01387269Phase 3
Sponsor listed in the registry: Helsinn Therapeutics (U.S.), Inc · Helsinn Therapeutics (U.S.), Inc — acquired company within the Helsinn Healthcare SA group
- Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study (ROMANA 3)CompletedNCT01395914Phase 3
Sponsor listed in the registry: Helsinn Therapeutics (U.S.), Inc · Helsinn Therapeutics (U.S.), Inc — acquired company within the Helsinn Healthcare SA group
- Safety and Efficacy of Ipamorelin for Management of Post-Operative IleusCompletedNCT00672074Phase 2
Sponsor listed in the registry: Helsinn Therapeutics (U.S.), Inc · Helsinn Therapeutics (U.S.), Inc — acquired company within the Helsinn Healthcare SA group
- Dose Range Study of Anamorelin in Patients With Non-small Cell Lung CancerCompletedNCT00622193Phase 2
Sponsor listed in the registry: Helsinn Therapeutics (U.S.), Inc · Helsinn Therapeutics (U.S.), Inc — acquired company within the Helsinn Healthcare SA group
- Safety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal FunctionCompletedNCT01280344Phase 2
Sponsor listed in the registry: Helsinn Therapeutics (U.S.), Inc · Helsinn Therapeutics (U.S.), Inc — acquired company within the Helsinn Healthcare SA group
- Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/CachexiaCompletedNCT00378131Phase 2
Sponsor listed in the registry: Helsinn Therapeutics (U.S.), Inc · Helsinn Therapeutics (U.S.), Inc — acquired company within the Helsinn Healthcare SA group
- Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia.CompletedNCT00267358Phase 2
Sponsor listed in the registry: Helsinn Therapeutics (U.S.), Inc · Helsinn Therapeutics (U.S.), Inc — acquired company within the Helsinn Healthcare SA group
- Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight LossCompletedNCT00219817Phase 2
Sponsor listed in the registry: Helsinn Therapeutics (U.S.), Inc · Helsinn Therapeutics (U.S.), Inc — acquired company within the Helsinn Healthcare SA group